Preventing renal failure in patients with severe lupus nephritis

Kidney International, Supplement

Volumn 67, Issue 94, 2005, Pages

  Chan, Tak Mao ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyclophosphamide; Mycophenolate mofetil; Remission

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; IMMUNOSUPPRESSIVE AGENT;

ALOPECIA; AMENORRHEA; CELL LOSS; CONFERENCE PAPER; EARLY DIAGNOSIS; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRON; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENCY; DRUG TOLERANCE; FOLLOW UP; HYPERLIPIDEMIA; HYPERTENSION; LONG TERM CARE; RELAPSE; REMISSION; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; REVIEW;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS;

EID: 15944403449     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. LEONHARDT T: Long-term prognosis of systemic lupus erythematosus. Acta Med Scand 445(Suppl):440-443, 1966
2. KORBET SM, LEWIS EJ, SCHWARTZ MM, et al: Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904-914, 2000
3. BONO L, CAMERON JS, HICKS JA: The very long-term prognosis and complications of lupus nephritis and its treatment. Q J Med 92:211-218, 1999
4. AUSTIN HA III, KLIPPEL JH, BALOW JE, et al: Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619, 1986
5. LEVEY AS, LAN SP, CORWIN HL, et al: Progression and remission of renal disease in the lupus nephritis collaborative study. Ann Intern Med 116:114-123, 1992
6. DONADIO JV, JR., HOLLEY KE, FERGUSON RH, ILSTRUP DM: Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151-1155, 1978
7. ILLEI GG, AUSTIN HA III, CRANE M, et al: Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 135:248-257, 2001
8. STEINBERG AD, STEINBERG SC: Long-term preservation of renal functions in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945-950, 1991
9. GOURLEY MF, AUSTIN HA 3RD, SCOTT D, et al: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 125:549-557, 1996
10. BOUMPAS DT, AUSTIN HA, VAUGHN EM, et al: Controlled trial of pulse methylprednisolone versus two regimens of pulse CYC in severe lupus nephritis. Lancet 340:741-745, 1992
11. HOUSSIAU FA, VASCONCELOS C, D'CRUZ D, et al: Immunosuppressive therapy in lupus nephritis. Arthritis Rheum 46:2121-2131, 2002
12. CHAN TM, CHENG IKP, LI FK, et al: Sequential therapy for diffuse proliferative and membranous lupus nephritis: Cyclophosphamide and prednisolone followed by azathioprine and prednisolone. Nephron 71:321-327, 1995
13. IOANNIDIS JPA, BOKI KA, KATSORIDA ME, et al: Remission, relapse, and re-remission of proliferaive lupus nephritis treated with cyclophosphamide. Kidney Int 57:258-264, 2000
14. ILLEI GG, TAKADA K, PARKIN D, et al: Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy. Arthritis Rheum 46:995-1002, 2002
15. MOK CC, HO CTK, SIU YP, et al: Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens. Am J Kidney Dis 38:256-264, 2001
16. CHAN TM, TSE KC, TANG CSO, et al: Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. Lupus 14:1-8, 2005
17. CHAN TM, LI FK, TANG CSO, et al: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343:1156-1162, 2000
18. CONTRERAS G, PARDO V, LECLERCQ B, et al: Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971-980, 2004
19. DONADIO JV, JR., HART GM, BERGSTRALH EJ, HOLLEY KE: Prognostic determinants in lupus nephritis: A long-term clinicopathologic study. Lupus 4:109-115, 1995
20. GINZLER EM, DIAMOND HS, WEINER M, et al: A multicenter study of outcome of systemic lupus erythematosus: I. Entry variables as predictors of progress. Arthritis Rheum 25:601-611, 1982
21. NAJAFI CC, KORBET SM, LEWIS EJ, et al: Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59:2156-2163, 2001
22. EL HACHMI M, JADOUL M, LEFEBVRE C, et al: Relapses of lupus nephritis: Incidence, risk factors, serology, and impact on outcome. Lupus 12:692-696, 2003
23. CLARK WF, MOIST LM: Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus 7:649-653, 1998
24. JAFAR TH, STARK PC, SCHMID CH, et al: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60:1131-1140, 2001
25. TANG S, LEUNG JCK, ABE K, et al: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells: An in vitro and in vivo study. J Clin Invest 111:515-527, 2003
26. ASANUMA Y, OESER A, SHINTANI AK, et al: Premature coronary-artery atherosclerosis in systemic lupus erythmatosus. N Engl J Med 349:2407-2415, 2003
27. ROMAN MJ, SHANKER B, DAVIS A, et al: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399-2406, 2003
28. WARD MM, PYUN E, STUDENSKI S: Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 38:1492-1499, 1995
29. FIEHN C, HAJJAR Y, MUELLER K, et al: Improved clinical outcome of lupus nephritis during the past decade: Importance of early diagnosis and treatment. Ann Rheum Dis 62:435-439, 2003